Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL
Clinical trial NCT05153330 · TERMINATED
Trial details
- NCT number
- NCT05153330
- Sponsor
- Biomea Fusion Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-24
- Primary completion
- 2025-02-13
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.